Komori

Corporate Governance Report 2026/09/09

A corporate governance report has been filed, showing schematic diagrams of the corporate governance structure and the timely disclosure structure. However, the body of the report does not specify any changes to the institutional design, officer composition or other details.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Governance structure

Committee1
Audit and Supervisory Committee
Changes this time

Schematic diagrams of the corporate governance structure and timely disclosure structure are included, but no changes from the previous report are stated.

Governance structure
ItemDetails
CommitteeAudit and Supervisory Committee (proportion of outside members: Not disclosed)
Changes this timeSchematic diagrams of the corporate governance structure and timely disclosure structure are included, but no changes from the previous report are stated.
Items this document does not state (6)
Corporate Governance StructureNumber of directorsNumber of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No explanation is provided for the reason for filing or for any changes, other than the filing of the report and inclusion of the schematic diagrams.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Corporate Governance Report 2026/09/09 | COSMOS Pharmaceutical Corporation (3349) timely disclosure | Komori